The objective of this study is to develop a methodology for effecting and assessing retroviral mediated gene transfer into human hematopoietic pluripotent progenitor cells (HPPCs). This study is part of an ongoing effort to develop an effective protocol utilizing ex-vivo retroviral vector mediated gene transfer into bone marrow followed by bone marrow autologous transplantation for the correction of lethal hematopoietic genetic disorders. Following bone marrow transplantation, a small population of cells, the hematopoietic pluripotent progenitor cells (HPPCs), give rise to stem cells with progressively restricted differentiation and self renewal potential and ultimately, mature cells. Recent murine studies indicate that long term, consistent transduction of the multiple lineages of the hematopoietic system will occur only if genes are transferred into the HPPC population at high efficiency. Studies to date investigating retroviral mediated gene transfer into human hematopoietic cells have assessed gene transfer only in mature, committed stem cell populations and have demonstrated low gene transfer frequencies. The studies described in this proposal are aimed at developing a general methodology for high efficiency retroviral mediated gene transfer into the human HPPC population. The strategy to achieve this involves: 1) purification of human reconstituting progenitor cells 2) development of in vitro and murine models for assessing human primitive progenitor cells 3) development of a protocol for maximal activation of these cells without concomitant loss of reconstituting potential 4) development of sensitive and specific assay systems for determining retroviral mediated gene transfer frequency into small numbers of purified, activated progenitor cells and 5) recapitulating promising progenitor cell purification, activation, and retroviral mediated gene transfer protocols in a primate model to confirm gene transfer in actual reconstituting progenitors.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK042693-04
Application #
3243860
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Project Start
1990-06-01
Project End
1995-05-31
Budget Start
1993-06-01
Budget End
1994-05-31
Support Year
4
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Flasshove, M; Banerjee, D; Leonard, J P et al. (1998) Retroviral transduction of human CD34+ umbilical cord blood progenitor cells with a mutated dihydrofolate reductase cDNA. Hum Gene Ther 9:63-71
Frey, B M; Hackett, N R; Bergelson, J M et al. (1998) High-efficiency gene transfer into ex vivo expanded human hematopoietic progenitors and precursor cells by adenovirus vectors. Blood 91:2781-92
Frey, B M; Rafii, S; Teterson, M et al. (1998) Adenovector-mediated expression of human thrombopoietin cDNA in immune-compromised mice: insights into the pathophysiology of osteomyelofibrosis. J Immunol 160:691-9
Cannizzo, S J; Frey, B M; Raffi, S et al. (1997) Augmentation of blood platelet levels by intratracheal administration of an adenovirus vector encoding human thrombopoietin cDNA. Nat Biotechnol 15:570-3
Shapiro, F; Yao, T J; Moskowitz, C et al. (1997) Effects of prior therapy on the in vitro proliferative potential of stem cell factor plus filgrastim-mobilized CD34-positive progenitor cells. Clin Cancer Res 3:1571-8
Rafii, S; Mohle, R; Shapiro, F et al. (1997) Regulation of hematopoiesis by microvascular endothelium. Leuk Lymphoma 27:375-86
Ohwada, A; Rafii, S; Moore, M A et al. (1996) In vivo adenovirus vector-mediated transfer of the human thrombopoietin cDNA maintains platelet levels during radiation-and chemotherapy-induced bone marrow suppression. Blood 88:778-84
Yurasov, S V; Flasshove, M; Rafii, S et al. (1996) Density enrichment and characterization of hematopoietic progenitors and stem cells from umbilical cord blood. Bone Marrow Transplant 17:517-25
Flasshove, M; Banerjee, D; Bertino, J R et al. (1995) Increased resistance to methotrexate in human hematopoietic cells after gene transfer of the Ser31 DHFR mutant. Leukemia 9 Suppl 1:S34-7
Flasshove, M; Banerjee, D; Mineishi, S et al. (1995) Ex vivo expansion and selection of human CD34+ peripheral blood progenitor cells after introduction of a mutated dihydrofolate reductase cDNA via retroviral gene transfer. Blood 85:566-74

Showing the most recent 10 out of 13 publications